Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare® System in the Treatment of the Signs and Symptoms of Dry Eye Disease
Sponsor: Sight Sciences, Inc.
Terminated
Sponsor chose to change the study design.
Other terminated trials from Sight Sciences, Inc.
- Primary Open Angle Glaucoma · Phase PHASE4 · Jan 2025
- Glaucoma, Open-Angle · Phase NA · Nov 2022
- Glaucoma, Open-Angle · Phase NA · Mar 2021
- Glaucoma, Open-Angle · Phase NA · Jan 2021
- Open-Angle Glaucoma · Phase NA · Jan 2019
More terminations from Sight Sciences, Inc.
Other Dry Eye Syndromes trials with similar outcome
A NA clinical study on Dry Eye Syndromes, this trial is terminated or withdrawn. The trial is conducted by Sight Sciences, Inc. and has accumulated 12 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Oct 2025 — Present [monthly]
Terminated NA
-
Sep 2025 — Oct 2025 [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
▶ Show 7 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
-
Oct 2019 — Feb 2020 [monthly]
Terminated NA
-
Mar 2019 — Oct 2019 [monthly]
Terminated NA
-
Feb 2019 — Mar 2019 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Aug 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sight Sciences, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .